Skip to main content
Caplight Logo









Flex Vascular

Flex Vascular

Private
Plymouth, MinnesotaHealthcare & Life Scienceshttps://www.flexvascular.com/

Last Round

Series C

Oct 29, 2025

Total Funding Raised

$51M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Flex Vascular is a medical device company that develops and markets endovascular medical devices for the treatment of peripheral arterial disease and stenoses of arteriovenous fistulas and grafts.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceendovascular technologyvessel preparationperipheral arterial diseasePADcatheter systemdialysis accessvascular surgeryinterventional radiologyangioplastystenosis treatmentvascular interventionmedtechinterventional hardwareminimally invasive surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Flex Vascular Comparables

Compare Flex Vascular with similar companies based on industry and business-model similarity.

Flex Vascular comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cagent Vascular
91%
Cardio Flow, Inc.
82%
Stryker Corporation
79%

Flex Vascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 29, 2025
Convertible DebtFeb 12, 2025
Convertible DebtJan 31, 2023
Convertible DebtNov 23, 2021
Series BAug 15, 2017
Series A
Dec 1, 2014

Key People

Founding team and executive leadership

John P. Pigott

FOUNDER, CHAIRMAN, CHIEF SCIENCE OFFICER

Founding Team

John Pigott

Founder, Chief Science Officer, Director-VentureMed Group, Founder, Chief Science Officer, Director- VentureMed Group

Founding Team

Denis Harrington

President CEO, Board Member

Executive Team

Flex Vascular Investors

Notable investors and investment history

Flex Vascular investors
InvestorRounds
RiverVest Venture PartnersConvertible Debt, Series B
Endeavour VisionConvertible Debt, Series C, Series B
S3 VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Bruce Fiedler appointed as Chief Financial Officer.

  • Oct 29, 2025

    $28M round completed.

Flex Vascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Flex Vascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Flex Vascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlymouth, Minnesota
Employee Range33
Year Founded2012
Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?